Paper33716004
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
Ciardullo S and 1 other. Metabolism, 2021. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes. Papers, record 33716004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33716004
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Liver Cirrhosis | Major topic |
| Aged | |
| Cross-Sectional Studies | |
| Disease Progression | |
| Elasticity Imaging Techniques | |
| Female | |
| Humans | |
| Italy | |
| Liver | |
| Male | |
| Middle Aged | |
| Non-alcoholic Fatty Liver Disease | |
| Nutrition Surveys | |
| Prevalence |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05987748 | The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD? | Background |
Source ClinicalTrials.gov
Cited by72
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877484 | The association of cardiovascular disease (CVD) with progression of advanced fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). | Livers | 2026 | https://conductscience.org/library/papers/42877484 | PubMed |
| 42872191 | Metabolic dysfunction-associated steatotic liver disease assessment and management: Clinical practice guidance from the Canadian Association for the Study of the Liver. | Can Liver J | 2026 | https://conductscience.org/library/papers/42872191 | PubMed |
| 41970192 | Metabolic Dysfunction-associated Steatotic Liver Disease and Chronic Kidney Disease: From Epidemiology and Pathophysiology to Clinical Prediction and Treatment Options. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/41970192 | PubMed |
| 41718130 | Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/41718130 | PubMed |
| 41676424 | High-density lipoprotein cholesterol and nuclear factor I A in type 2 diabetes and mild cognitive impairment: biomarkers and mechanistic insights. | Arch Med Sci | 2025 | https://conductscience.org/library/papers/41676424 | PubMed |
| 41522334 | Transient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today's World. | Curr Hepatol Rep | 2025 | https://conductscience.org/library/papers/41522334 | PubMed |
| 41455979 | The importance of sex dimorphism in liver metabolism and progressive liver diseases. | Biol Sex Differ | 2025 | https://conductscience.org/library/papers/41455979 | PubMed |
| 41356318 | Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41356318 | PubMed |
| 41324115 | Correlation of Lymphocyte-to-C-Reactive Protein Ratio With Erectile Dysfunction Risk in United States Adult Males during 2001-2004: A Cross-Sectional Analysis. | Health Sci Rep | 2025 | https://conductscience.org/library/papers/41324115 | PubMed |
| 41127403 | Knowledge, Attitudes, and Practices of Elderly Diabetic Patients and Their Families Regarding Comorbid Non-Alcoholic Fatty Liver Disease: A Structural Equation Modeling Analysis. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/41127403 | PubMed |
| 41113904 | Proteome Profiling Identifies CDH2 as a Potential Screening Marker for NAFLD and Liver Fibrosis in the Snoring Population. | Nat Sci Sleep | 2025 | https://conductscience.org/library/papers/41113904 | PubMed |
| 41026784 | Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients. | PLoS One | 2025 | https://conductscience.org/library/papers/41026784 | PubMed |
| 40937081 | Assessment of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Cross-sectional Study in Asymptomatic Individuals in Greater Vancouver. | J Clin Transl Hepatol | 2025 | https://conductscience.org/library/papers/40937081 | PubMed |
| 40630174 | The association of dietary nutrients consumption with hepatic steatosis and fibrosis from NHANES 2017-2020. | Front Nutr | 2025 | https://conductscience.org/library/papers/40630174 | PubMed |
| 40596311 | Utility of the serum alanine aminotransferase to high density lipoprotein cholesterol ratio in evaluating nonalcoholic fatty liver disease and liver fibrosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40596311 | PubMed |
| 40427477 | Protective Effects of Lotus Seedpod Extract on Hepatic Lipid and Glucose Metabolism via AMPK-Associated Mechanisms in a Mouse Model of Metabolic Syndrome and Oleic Acid-Induced HepG2 Cells. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427477 | PubMed |
| 40425766 | Nonlinear relationship between serum high sensitivity C reactive protein to high density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease. | Sci Rep | 2025 | https://conductscience.org/library/papers/40425766 | PubMed |
| 40333820 | Relationship between the systemic immune-inflammatory index and overactive bladder risk: A cross-sectional assessment involving United States Adults. | PLoS One | 2025 | https://conductscience.org/library/papers/40333820 | PubMed |
| 40251275 | Mortality among individuals with chronic kidney disease based on the 2012 and 2021 KDIGO blood pressure targets. | Sci Rep | 2025 | https://conductscience.org/library/papers/40251275 | PubMed |
| 40226389 | Factors Associated With Advanced Liver Fibrosis in a Population With Type 2 Diabetes: A Multicentric Study in Mexico City. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40226389 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33716004
GET https://conductscience.org/api/papers/v1/33716004/cited_by?page=2